Mark your calendars because the R. Bryan Miller Symposium returns this April for its first in-person event since 2020. Featuring a stellar lineup of high-profile speakers and leading-edge researchers in chemical biology, organic, medicinal and pharmaceutical chemistry, the 23rd annual symposium creates a pipeline between academia and industry, allowing students to network, present their research and learn skills pivotal to their future professional careers. The free event is scheduled for April 13 and 14 at the UC Davis Conference Center.

Distinguished Professor of Chemistry Carlito B. Lebrilla and other UC Davis researchers are paving a path to commercialize a new technology that they hope will make dietary fiber easier to add into food and more acceptable to the consumer. The novel depolymerization technology can chop up fiber from long polysaccharides into small, bioactive chains of carbohydrates, called oligosaccharides. The process doesn't change the structure of the fiber, but makes it soluble, digestible and palatable.

Created over 10 years ago by Professor of Chemistry Jared Shaw, the Davis Science Café meets on the second Wednesday of each month to provide an avenue for the community to learn about the current state of science across its many disciplines.

A $4 million award from the California Education Learning Lab will help expand an innovative, open education project founded by a UC Davis College of Letters and Science professor. LibreTexts is an online textbook platform that aims to “unite students, faculty and scholars in a cooperative effort to develop an easy-to-use online platform for the construction, customization and dissemination of open educational resources to reduce the burdens of unreasonable textbook costs.”

Two College of Letters and Science faculty members are among 125 recipients of this year’s Sloan Research Fellowships, prestigious awards given by the Alfred P. Sloan Foundation to early-career scientific researchers seen as emerging leaders in their fields.

The 2023 fellows, including UC Davis’ Jesús M. Velázquez and Alexander S. Wein, “represent the most promising scientific researchers working today,” the Alfred P. Sloan Foundation said in announcing its selections Feb. 15.

Location, location, location is the key for psychedelic drugs that could treat mental illness by rapidly rebuilding connections between nerve cells. In a paper published Feb. 17 in Science, researchers at the University of California, Davis, show that engaging serotonin 2A receptors inside neurons promotes growth of new connections but engaging the same receptor on the surface of nerve cells does not.

The University of California, Davis, has launched the Institute for Psychedelics and Neurotherapeutics to advance basic knowledge about the mechanisms of psychedelics and translate it into safe and effective treatments for diseases such as depression, post-traumatic stress disorder, addiction, Alzheimer’s disease and Parkinson’s disease, among others.

Five faculty from the UC Davis College of Letters and Science were recently elected as new fellows of the American Association for the Advancement of Science, the society announced Jan. 31.

Design2Data is a course-based undergraduate research experience (CURE) that teaches students an enzyme design-build-test workflow, allowing them to contribute knowledge to an open access database. Since its launch, the course has been rolled out to 25 institutions across the nation.

There’s no word in Bao Vue’s native language for “chemistry.” The science subject is not easily expressed in Hmong vocabulary. In fact, the same can be said for the concept of “science” itself. But when Vue was 9 years old, she and her family fled their home for safety. Today, she's a chemistry doctoral candidate in UC Davis Professor of Chemistry Jacquelyn Gervay-Hague’s lab, which is focused on developing sustainable methods to produce antiviral and anticancer agents from natural products.